Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58023-19-1

NSC 240403, also known as N,N-Bis(2-chloroethyl)benzenesulfonamide, is a chemical compound that serves as a novel intermediate in the synthesis of Cetirizine (C281100). It is a significant component in the pharmaceutical industry due to its role in the production of Cetirizine, which is an antihistamine drug used to treat various allergic conditions.

58023-19-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 58023-19-1 Structure

  • Basic information

    1. Product Name: NSC 240403
    2. Synonyms: N,N-Bis(2-chloroethyl)benzenesulfonaMide;NSC 240403
    3. CAS NO:58023-19-1
    4. Molecular Formula: C10H13Cl2NO2S
    5. Molecular Weight: 282.18672
    6. EINECS: N/A
    7. Product Categories: Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds
    8. Mol File: 58023-19-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 398.4°Cat760mmHg
    3. Flash Point: 194.7°C
    4. Appearance: /
    5. Density: 1.338g/cm3
    6. Vapor Pressure: 1.48E-06mmHg at 25°C
    7. Refractive Index: 1.554
    8. Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
    9. Solubility: Chloroform, Ethyl Acetate, Methanol
    10. Stability: Hygroscopic
    11. CAS DataBase Reference: NSC 240403(CAS DataBase Reference)
    12. NIST Chemistry Reference: NSC 240403(58023-19-1)
    13. EPA Substance Registry System: NSC 240403(58023-19-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 58023-19-1(Hazardous Substances Data)

58023-19-1 Usage

Uses

Used in Pharmaceutical Industry:
NSC 240403 is used as a key intermediate in the synthesis of Cetirizine (C281100) for its antihistamine properties. NSC 240403 plays a crucial role in the development of medications that help alleviate symptoms of allergies, such as sneezing, itching, and runny nose, by blocking the effects of histamine in the body.

Check Digit Verification of cas no

The CAS Registry Mumber 58023-19-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,0,2 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 58023-19:
(7*5)+(6*8)+(5*0)+(4*2)+(3*3)+(2*1)+(1*9)=111
111 % 10 = 1
So 58023-19-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H13Cl2NO2S/c11-6-8-13(9-7-12)16(14,15)10-4-2-1-3-5-10/h1-5H,6-9H2

58023-19-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-Bis(2-chloroethyl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names N,N-bis(2-chloroethyl)benzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58023-19-1 SDS

58023-19-1Relevant articles and documents

PROCESS FOR PREPARATION OF SUBSTANTIALLY OPTICALLY PURE LEVOROTATORY AND DEXTROROTATORY ENANTIOMERS OF CETIRIZINE USING NOVEL INTERMEDIATES

-

Page/Page column 2-3, (2009/12/04)

The present invention relates to a novel and commercially viable process for substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine intermediate, 1-[(4-chlorophenyl)phenylmethyl]piperazine, thereby producing substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine and their pharmaceutical acceptable acid addition salts thereof in high purity and in high yield using novel intermediates.

PROCESS FOR PREPARATION OF SUBSTANTIALLY OPTICALLY PURE LEVOROTATORY AND DEXTROROTATORY ENANTIOMERS OF CETIRIZINE USING NOVEL INTERMEDIATES

-

Page/Page column 5-6, (2009/01/24)

The present invention relates to a novel and commercially viable process for substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine intermediate, 1-[(4-chlorophenyl)phenylmethyl]piperazine, thereby producing substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine and their pharmaceutical acceptable acid addition salts thereof in high purity and in high yield using novel intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58023-19-1